Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy

Annals of Internal Medicine

Volumn 137, Issue 8, 2002, Pages 656-659

  Bernard, Louis ^a   Vuagnat, Albert ^a   Peytavin, Gilles ^a   Hallouin, Marie Charlotte ^a   Bouhour, Damien ^a   Nguyen, Thu Huyen ^a   Vildé, Jean Louis ^a   Bricaire, François ^a   Raguin, Gilles ^a   De Truchis, Pierre ^a   Ghez, David ^a   Duong, Michel ^a   Perronne, Christian ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; PROTEINASE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; HAIR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; VIREMIA;

EID: 0037108772     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-8-200210150-00009     Document Type: Article

References (18)

1. Hirschel B, Francioli P. Progress and problems in the fight against AIDS [Editorial]. N Engl J Med. 1998;338:906-8. [PMID: 9516228]
2. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337:725-33. [PMID: 9287227]
3. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999;13(Suppl 1):S61-72. [PMID: 10546786]
4. Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF. Patient compliance and drug failure in protease inhibitor monotherapy [Letter]. JAMA. 1996;276:1955-6. [PMID: 8971062]
5. Condra JH, Schleif WA, Blahy OM, Gabryelski LJ, Graham DJ, Quintero JC, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 1995;374:569-71. [PMID: 7700387]
6. Condra JH. Resistance to HIV protease inhibitors. Haemophilia. 1998;4:610-5. [PMID: 9873802]
7. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;3:261-9. [PMID: 8827119]
8. Woolf E, Au T, Haddix H, Matuszewski B. Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching. J Chromatogr A. 1995;692:45-52. [PMID 7719460]
9. Bernard L, Peytavin G, Vuagnat A, de Truchis P, Perronne C. Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy [Letter]. Lancet. 1998;352:1757-8. [PMID: 9848361]
10. Nakahara Y. Hair analysis for abused and therapeutic drugs. J Chromatogr B Biomed Sci Appl. 1999;733:161-80. [PMID: 10572981]
11. Kintz P, Tracqui A, Mangin P. Pharmacological studies on meprobamate incorporation in human beard hair. Int J Legal Med. 1993;105:283-7. [PMID: 8471546]
12. Graham K, Koren G, Klein J, Schneiderman J, Greenwald M. Determination of gestational cocaine exposure by hair analysis. JAMA. 1989;262:3328-30. [PMID: 2585678]
13. Tracqui A, Kreissig P, Kintz P, Pouliquen A, Mangin P. Determination of amitriptyline in the hair of psychiatric patients. Hum Exp Toxicol. 1992;11:363-7. [PMID: 1358152]
14. Nijhuis M, Boucher CA, Schipper P, Leitner T, Schuurman R, Albert J. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc Natl Acad Sci U S A. 1998;95:14441-6. [PMID: 9826719]
15. Condra JH, Holder DJ, Schleif WA, Blahy OM, Danovich RM, Gabryelski LJ, et al. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol. 1996;70:8270-6. [PMID: 8970946]
16. Hirsch MS, Brun-Vézinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA. 2000;283:2417-26. [PMID: 10815085]
17. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford, United Kingdom: Clarendon Pr; 1994.
18. Condra JH. Resisting resistance: maximizing the durability of antiretroviral therapy [Editorial]. Ann Intern Med. 1998;128:951-4. [PMID: 9634437]